Kotagiri, N
From an experimental perspective, this means that BPC-157 can be used as a tool to study angiogenesis, endothelial signaling and the organization of the vascular response in in vitro and in vivo models
A separate product, semaglutide subcutaneous injection (Wegovy), is indicated as an adjunct to lifestyle modifications for weight loss and chronic weight management in obese (BMI 30 kg/m2 or greater) or overweight adults (BMI 27 kg/m2 or greater) with at least 1 weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
For a detailed overview of how Australian peptide regulation works, see our guide to peptide legality and TGA compliance in Australia
Cardiovascular morbidity, diabetes and cancer risk among children and adolescents with severe obesity
Fitzpatrick J, Bulsara MK, O'Donnell J, McCrory PR, Zheng MH